Varicella zoster virus infection
Basic details
Preferred term: Varicella zoster virus infection
Alt. terms: VZV infection | herpes zoster infection | Human herpesvirus 3 infection | chickenpox | shingles
HPO term: Severe varicella zoster infection
HPO code: HP:0032170
GenIA ID: 529
Last updated on: 2024-04-25 14:48:58
Cross ref. with other ontologies
NCIT: C71079
MESH: D006562
EFO:0006510
OAE: -
SNOMEDCT: -
ICD10: B02
Description
A common dermal and neurologic disorder caused by reactivation of the varicella-zoster virus that has remained dormant within dorsal root ganglia, often for decades, after the patient's initial exposure to the virus in the form of varicella (chickenpox). It is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. In the majority of the cases, especially in children, varicella is a very mild infection characterised by skin lesions, low grade fever and malaise. Severe infection is characterized by manifestions including VZV pneumonia, hepatitis, meningitis, and disseminated varicella. Varicella-zoster virus (VZV) is one of eight herpes viruses known to cause human infection and is distributed worldwide. Varicella zoster infections are considered to be mild and ubiquitous infections predominantly affecting the paediatric population. However, in adults and in specific groups of patients, such as those who are immunosuppressed, varicella infections can be fulminant and life threatening.
Hierarchical classification
TERM
Varicella zoster virus infection
CHILD terms
Reported patients added to GenIA DB
SubjectID | Sex | Fam.ID | Age* | Population | MatchedTerm | Diagnosis | Reference & Pub.codes |
---|---|---|---|---|---|---|---|
101015 | M | 210203 | -,- | German | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.MM:II.1]; PMID:29729943 [Fam.MM:II.1(87)]; PMID:34975878 [Fam.F002:P002]; PMID:31857261 [Patient 3] |
101020 | F | 210008![]() |
28 | German | Herpes Simplex Virus Infection | NFKB1 insufficiency | PMID:34975878 [Fam.F005:P005]; PMID:32278790 [Fam.AU:II.3(II.3)]; PMID:29403474 [Patient 28 (11)]; PMID:150198 [Fam.AM:II.4(157)]; PMID:27461466 [Fam.199_01:28] |
101021 | M | 210359 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F006:P006] | |
101022 | M | 210482 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F007:P007] | |
101026 | M | 210215 | 16 | Varicella zoster virus infection | PMID:34975878 [Fam.F011:P011] | ||
101028 | F | 210750 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F013:P013] | |
101037 | M | 210182![]() |
- | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.4(B.II.3)]; PMID:30250467 [B.II.3]; PMID:29729943 [Fam.B:II.4(B.II.3 (15))]; PMID:27418640 [P13(5)] |
101038 | F | 210182![]() |
- | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.B:II.6(B.II.4)]; PMID:30250467 [B.II.4]; PMID:29729943 [Fam.B:II.6(B.II.4 (16))]; PMID:34975878 [Fam.F014:III.6(P015)]; PMID:27418640 [P14(5)] |
101043 | M | 210725![]() |
- | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.H:II.2(30)]; PMID:34975878 [Fam.F017:P017] |
101076 | F | 210226 | 11 | German | Varicella zoster virus infection | PMID:34975878 [Fam.F041:P041] | |
101078 | F | 211301 | 53 | Varicella zoster virus infection | PMID:34975878 [Fam.F044:P044] | ||
101081 | F | 211315 | 45 | Varicella zoster virus infection | PMID:34975878 [Fam.F047:P047] | ||
101082 | F | 211226 | - | (unusual) Viral infection | Adenosine deaminase 2 deficiency | PMID:34975878 [Fam.F048:P048] | |
101086 | M | 210934 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F052:P052] | |
101088 | M | 211560 | 22 | German | Varicella zoster virus infection | PMID:34975878 [Fam.F054:P054] | |
101091 | M | 210911 | 15 | Varicella zoster virus infection | DiGeorge syndrome | PMID:34975878 [Fam.F057:P057]; PMID:35486341 [P180] | |
101093 | M | 211289 | 28,- | German | (unusual) Viral infection,Varicella zoster virus infection | Immunodeficiency, common variable, 8 | PMID:34975878 [Fam.F059:P059]; PMID:31857261 [Patient 4] |
101115 | F | 210778 | - | Caucasian | (unusual) Viral infection | NFKB1 insufficiency | PMID:34975878 [Fam.F069:P069]; PMID:32278790 [AC.I.1]; PMID:150198 [Fam.CK:427] |
101124 | F | 210216 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F075:P075] | |
101127 | F | 210318 | 32 | German | Varicella zoster virus infection | PMID:34975878 [Fam.F077:P077] | |
101129 | F | 210906 | 32,37 | German | Herpes Simplex Virus Infection,Varicella zoster virus infection | PMID:34975878 [Fam.F078:P078] | |
101130 | F | 210465 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F079:P079] | |
101131 | F | 210337 | 6 | German | Varicella zoster virus infection | PMID:34975878 [Fam.F080:P080] | |
101132 | M | 210304 | 5 | German | Varicella zoster virus infection | PMID:34975878 [Fam.F081:P081] | |
101133 | M | 210896 | 40 | Varicella zoster virus infection | Immunodeficiency, common variable, 13 | PMID:34975878 [Fam.F082:P082] | |
101135 | F | 210574 | 11 | Varicella zoster virus infection | PMID:34975878 [Fam.F084:P084] | ||
101143 | F | 211219 | 32 | Varicella zoster virus infection | PMID:34975878 [Fam.F088:P088] | ||
101146 | F | 211132 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F089:P089] | |
101153 | M | 210757 | -,15 | German | Herpes Simplex Virus Infection,Varicella zoster virus infection | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES55] |
101155 | M | 210235 | -,- | German | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [JJ.II.I]; PMID:29729943 [Fam.JJ:II.1(83)]; PMID:34975878 [Fam.F098:P098] |
101160 | F | 211433 | 45,- | (unusual) Viral infection,Varicella zoster virus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F101:P101] | |
101162 | F | 211457 | 9 | Varicella zoster virus infection | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F103:P103] | |
101164 | F | 211460 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F105:P105] | |
101167 | M | 211470![]() |
-,48 | Herpes Simplex Virus Infection,Varicella zoster virus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F108:P108]; PMID:33486103 [Fam.1:II.1(patient)]; PMID:150198 [Fam.DT:II.1(510)] | |
101178 | M | 210542 | 25 | Varicella zoster virus infection | PMID:34975878 [Fam.F114:P114] | ||
101189 | M | 211486 | 41 | Varicella zoster virus infection | PMID:34975878 [Fam.F120:P120] | ||
101197 | F | 214344 | - | Egyptian | Herpes Simplex Virus Infection | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES18] |
101199 | F | 211483 | 23 | German | Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.YY:II.1(127)]; PMID:34975878 [Fam.F122:P122] |
101201 | F | 211487 | - | Varicella zoster virus infection | Immunodeficiency, common variable, 10 | PMID:34975878 [Fam.F123:II.3(P123)]; PMID:30941118 [Fam.1404:II.3(Pt#22)] | |
101204 | M | 211492 | - | German | Varicella zoster virus infection | PMID:34975878 [Fam.F126:P126] | |
101382 | M | 210641 | 20 | German | Herpes Simplex Virus Infection | Immunodeficiency, common variable, 1 | PMID:15507387 [Fam.C:II.3(II.3)]; PMID:16384931 [Fam.C:II.3(P5)]; PMID:19426217 [Fam.C:II.3(P5)]; PMID:28861081 [Fam.3:II.3(P5)] |
101403 | M | 210189![]() |
- | German | Herpes Simplex Virus Infection | Adenosine deaminase 2 deficiency | PMID:28493328 [P3]; PMID:26922074 [Index(II.2)] |
101410 | F | 210902 | -,41 | German | Herpes Simplex Virus Infection,Varicella zoster virus infection | Adenosine deaminase 2 deficiency | PMID:34975878 [Fam.F141:P141]; PMID:28493328 [P4] |
101416 | M | 212169 | - | Turkish | Varicella zoster virus infection | Immunodeficiency, common variable, 8 | PMID:27146671 [Patient(II.1)] |
101425 | M | 210205![]() |
- | Caucasian | Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.A:II.8(A.II.5)]; PMID:29729943 [Fam.A:II.8(A.II.5 (4))]; PMID:27418640 [P7(5)] |
101444 | F | 210640 | 18 | Varicella zoster virus infection | PMID:34975878 [Fam.F145:P145] | ||
101450 | F | 210409 | 10 | German | Varicella zoster virus infection | PMID:34975878 [Fam.F149:P149] | |
101453 | F | 210192 | 20 | German | Varicella zoster virus infection | Immunodeficiency, common variable, 13 | PMID:34975878 [Fam.F150:P150]; PMID:31057532 [Fam.A:I.2] |
101457 | F | 211027 | - | Varicella zoster virus infection | PMID:34975878 [Fam.F152:P152] | ||
101461 | M | 210929 | 45 | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F153:P153]; PMID:32278790 [Z.I.1]; PMID:29403474 [Patient 27 (11)]; PMID:27923702 [Patient 6]; PMID:150198 [Fam.AL:151]; PMID:27461466 [Fam.830_01:27] |
101469 | F | 210220![]() |
11 | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F156:P156]; PMID:32278790 [Fam.089:II.2(II.2)]; PMID:26279205 [Fam.089:II.2(II2)]; PMID:29403474 [Fam.089 (5):II.2(II2)]; PMID:27923702 [Patient 5]; PMID:150198 [Fam.AB:IV.5(099)]; PMID:27461466 [Fam.089:II.2(25)] |
101479 | F | 210314![]() |
18 | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F160:P160]; PMID:32278790 [Fam.BF:II.2(II.2)]; PMID:29403474 [Fam.(13):II.1(Patient 2)]; PMID:27923702 [Fam.191:II.1(Patient 2)]; PMID:150198 [Fam.AO:II.2(164)]; GRID:001142 [Fam.#:II.2(FR036)] |
101491 | F | 212457 | - | Hungarian | Varicella zoster virus infection | Severe combined immunodeficiency 9A, T-B- | PMID:29410113 [Patient(II.1)] |
101495 | M | 212458 | 1 | Taiwanese | Varicella zoster virus infection | Activated p110-delta syndrome 1 | PMID:16984281 [P3(II.1)] |
101512 | M | 212459 | - | British | Herpes Simplex Virus Infection | Activated p110-delta syndrome 1 | PMID:24136356 [Fam.A:III.4(P3)] |
101514 | M | 210220![]() |
- | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.089:I.1(I.1)]; PMID:26279205 [Fam.089:I.1(I1)]; PMID:29403474 [Fam.089 (5):I.1(I1)]; PMID:150198 [Fam.AB:III.3(093)]; PMID:27461466 [Fam.089:I.1(24)] |
101526 | F | 212460 | - | British | Herpes Simplex Virus Infection | PMID:24136356 [Fam.B:III.1] | |
101541 | M | 212461 | - | Slovenian | Herpes Simplex Virus Infection | Activated p110-delta syndrome 1 | PMID:24136356 [Fam.C:II.1(P8)] |
101549 | F | 212463 | - | British | Herpes Simplex Virus Infection | Activated p110-delta syndrome 1 | PMID:24136356 [Fam.E:I.1(P13)] |
101551 | M | 212463 | - | British | Herpes Simplex Virus Infection | Activated p110-delta syndrome 1 | PMID:24136356 [Fam.E:II.1(P12)] |
101553 | M | 210256 | - | German | Varicella zoster virus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:34975878 [Fam.F182:P182] |
101575 | M | 210900 | - | German | Varicella zoster virus infection | Adenosine deaminase 2 deficiency | PMID:34975878 [Fam.F198:P198]; PMID:28493328 [P2] |
101613 | F | 210737 | 14 | Varicella zoster virus infection | PMID:34975878 [Fam.F210:P210] | ||
101616 | F | 211098 | 11 | Varicella zoster virus infection | PMID:34975878 [Fam.F211:P211] | ||
101633 | M | 210945 | 3 | Varicella zoster virus infection | Immunodeficiency, common variable, 10 | PMID:34975878 [Fam.F220:P220]; PMID:30941118 [Fam.846:II.1(Pt#49)] | |
101635 | F | 211154 | 51 | German | Varicella zoster virus infection | Severe combined immunodeficiency due to adenosine deaminase deficiency | PMID:34975878 [Fam.F221:P221] |
101639 | F | 210928 | - | Varicella zoster virus infection | PMID:34975878 [Fam.F222:P222] | ||
101651 | M | 210939 | - | Varicella zoster virus infection | PMID:34975878 [Fam.F226:P226] | ||
101665 | M | 211084 | - | Herpes Simplex Virus Infection | PMID:34975878 [Fam.F233:P233] | ||
101722 | F | 210261![]() |
- | Asian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:25329329 [Fam.D:II.1(D.II.1)]; PMID:29729943 [Fam.D:II.1(D.II.1 (22))]; PMID:27418640 [P18(5)] |
101732 | M | 210300![]() |
16 | North American | Varicella zoster virus infection | Immunodeficiency, common variable, 15 | PMID:28782633 [Fam.I:III.4(P3)] |
101768 | M | 210789 | - | Varicella zoster virus infection | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F250:P250] | |
101774 | M | 210908![]() |
- | Argentinian | Herpes Simplex Virus Infection | Adenosine deaminase 2 deficiency | PMID:28493328 [P9(II.1)] |
101775 | M | 210908![]() |
- | Argentinian | Herpes Simplex Virus Infection | Adenosine deaminase 2 deficiency | PMID:28493328 [Fam.P9:II.2(P10)] |
101789 | M | 210950![]() |
- | Swiss | Herpes Simplex Virus Infection | Adenosine deaminase 2 deficiency | PMID:28493328 [Fam.P7:II.2(P8)] |
101792 | M | 210991 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.NN:II.11(NN.II.9(92))] |
101794 | F | 211030 | - | Italian | Herpes Simplex Virus Infection | Adenosine deaminase 2 deficiency | PMID:28493328 [P5] |
101797 | M | 211108 | -,- | Caucasian | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.QQ:II.1(97)]; PMID:34975878 [Fam.F258:P258] |
101799 | M | 211120 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.XX:II.1]; PMID:29729943 [Fam.XX:II.1(126)] |
101808 | F | 211441 | 40 | Varicella zoster virus infection | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F265:P265] | |
101812 | F | 211521 | 3 | Varicella zoster virus infection | Immunodeficiency, common variable, 2 | PMID:34975878 [Fam.F271:P271] | |
101814 | F | 211527 | 68 | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:34975878 [Fam.F274:P274]; PMID:32278790 [AK.I.1]; PMID:150198 [Fam.CP:435] |
101821 | F | 210122 | 11 | Varicella zoster virus infection | PMID:34390440 [NEG027] | ||
101923 | F | 210092 | - | Varicella zoster virus infection | PMID:34390440 [NEG061] | ||
101959 | M | 210641 | 18 | German | Herpes Simplex Virus Infection | Immunodeficiency, common variable, 1 | PMID:15507387 [Fam.C:II.4(II.4)]; PMID:16384931 [Fam.C:II.4(P6)]; PMID:19426217 [Fam.C:II.4(P6)]; PMID:28861081 [Fam.3:II.4(P6)] |
102082 | U | 214302 | - | Egyptian | Herpes Simplex Virus Infection | Hyper-IgE recurrent infection syndrome 2 | PMID:34390440 [HIES11] |
102157 | F | 214681 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.R:II.5(45)] |
102175 | M | 210725![]() |
- | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [Fam.H:II.1]; PMID:29729943 [Fam.H:II.1(29)] |
102222 | M | 214917 | 4,53 | German | Herpes Simplex Virus Infection,Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [BY.I.1]; PMID:35486341 [P074]; PMID:150198 [Fam.DJ:467]; PMID:36105815 [W295C] |
102426 | F | 214949![]() |
9 | French | Varicella zoster virus infection | Hyper-IgE recurrent infection syndrome 4A | PMID:32207811 [Fam.A:III.2(P4)] |
102439 | M | 214956![]() |
- | Bulgarian | Varicella zoster virus infection | Hyper-IgE recurrent infection syndrome 4A | PMID:32207811 [Fam.C:II.2(P6)] |
102449 | F | 214958![]() |
2 | Mexican/Salvadoran | Varicella zoster virus infection | Hyper-IgE recurrent infection syndrome 4A | PMID:32207811 [Fam.E:II.1(P9)] |
102509 | M | 214948![]() |
- | Irish Traveller | (unusual) Viral infection | Immunodeficiency 54 | PMID:16532402 [Fam.A:IV.12(P3)]; PMID:22354167 [Fam.A:IV.12(P1.3)] |
102719 | F | 214981![]() |
0 | Canadian | (unusual) Viral infection | Autoinflammation, immune dysregulation, and eosinophilia | PMID:28111307 [Fam.1:II.2(Patient)]; PMID:36546480 [Fam.1:II.2(II-2)] |
102729 | M | 214981![]() |
0 | Canadian | (unusual) Viral infection | Autoinflammation, immune dysregulation, and eosinophilia | PMID:28111307 [Fam.1:III.1]; PMID:36546480 [Fam.1:III.1(III-1)] |
102730 | M | 214981![]() |
0 | Canadian | (unusual) Viral infection | Autoinflammation, immune dysregulation, and eosinophilia | PMID:28111307 [Fam.1:III.2]; PMID:36546480 [Fam.1:III.2(III-2)] |
102731 | F | 214982![]() |
- | Colombian | Herpes Simplex Virus Infection | Immunodeficiency 99 | PMID:32484799 [Patient(II.2)] |
102803 | F | 214991![]() |
8 | North American | Herpes Simplex Virus Infection | Immunodeficiency 8 | PMID:25073507 [P1(II.2)] |
102808 | M | 214992![]() |
1 | Turkish | Varicella zoster virus infection | Immunodeficiency 8 | PMID:26476480 [P1(II.1)] |
102815 | M | 214994 | - | (unusual) Viral infection | Immunodeficiency 8 | PMID:34913575 [Patient] | |
102881 | F | 215003![]() |
1 | Portuguese | Varicella zoster virus infection | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:20978268 [Fam.1:II.1(P1)]; PMID:33464451 [P3]; PMID:28077132 [P7]; PMID:22590644 [Patient(II.1)] |
102884 | M | 215004![]() |
0 | Admixed | Herpes Simplex Virus Infection | T-cell immunodeficiency, congenital alopecia, and nail dystrophy | PMID:20978268 [Fam.2:II.1(P2)]; PMID:33464451 [P4]; PMID:22721479 [Patient]; PMID:28077132 [P8] |
102935 | M | 215035![]() |
- | Caucasian | Herpes Simplex Virus Infection | T-cell lymphopenia with or without nail dystrophy, AD | PMID:31447097 [P24]; PMID:33464451 [Fam.P14:III.2(P15)]; PMID:37419334 [P15(27)] |
102962 | F | 215058![]() |
0 | North American | (unusual) Viral infection | T-cell immunodeficiency with thymic aplasia | PMID:31566583 [P1(II.1)]; PMID:37419334 [P1] |
103018 | M | 215085![]() |
- | Japanese | Herpes Simplex Virus Infection | Immunodeficiency 35 | PMID:17676033 [Tyk2 Pt]; PMID:17088085 [Patient] |
103051 | M | 215095![]() |
1,1 | Finnish | Herpes Simplex Virus Infection,Varicella zoster virus infection | Seizures, cortical blindness, microcephaly syndrome | PMID:33662367 [Fam.F1:II.7(P1)] |
103292 | F | 215114 | - | German | Varicella zoster virus infection | Immunodeficiency 82 with systemic inflammation | PMID:33782605 [P5] |
103478 | M | 215135![]() |
- | French | Varicella zoster virus infection | Immunodeficiency 55 | PMID:28414293 [Fam.B:II.1(P3)] |
103482 | F | 215136![]() |
2,1 | British | Herpes Simplex Virus Infection,Varicella zoster virus infection | Immunodeficiency 55 | PMID:28414293 [Fam.C:II.1(P4)] |
103880 | F | 215269![]() |
3 | Finnish | Varicella zoster virus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25038750 [P5]; PMID:25349174 [Fam.1:II.4(Patient 1)] |
103999 | M | 215320![]() |
- | Varicella zoster virus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P3] | |
104000 | M | 215321 | - | Varicella zoster virus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:25359994 [P4] | |
104444 | F | 215528![]() |
8 | Spanish | Herpes Simplex Virus Infection | Early-onset atopic inflammation | PMID:36884218 [Fam.B:II.2(P2)] |
104554 | M | 215551![]() |
- | Pakistani | Varicella zoster virus infection | Autoinflammation, panniculitis, and dermatosis syndrome | PMID:27523608 [Fam.1:V.2(V:2)]; PMID:27559085 [Fam.1:V.2(P1)]; PMID:35587511 [Fam.G:II.2(4)]; PMID:34797715 [P1]; PMID:38914362 [Fam.A:V.2(023)] |
104845 | F | 215579![]() |
15 | European | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.NZ:II.2(II.2)]; PMID:26279205 [Fam.NZ:II.2(II2)]; PMID:29403474 [Fam.NZ (5):II.2(II2)]; PMID:29806948 [Fam.NZ:II.2(II.2)]; PMID:30323807 [Fam.2:II.2(II.2)]; PMID:150198 [Fam.AC:II.2(109)] |
104886 | F | 215613![]() |
-,- | Caucasian | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.G:III.1(G.III.1 (26))]; PMID:25367873 [Fam.1:III.6(III.6)] |
104916 | M | 215613![]() |
-,- | Caucasian | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [G.III.2]; PMID:29729943 [Fam.G:III.2(G.III.2 (27))]; PMID:25367873 [Fam.1:III.5(III.5)] |
105057 | F | 215635![]() |
- | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [S.I.1]; PMID:29403474 [Patient 1 (8)]; PMID:27365489 [Fam.1:II.1(Pat.1)]; PMID:150198 [Fam.AE:II.1(121)] |
105075 | M | 215636 | 4 | Spanish | Varicella zoster virus infection | Combined immunodeficiency 36 | PMID:35464398 [P5(II.1)] |
105088 | M | 215638 | - | Japanese | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:26644313 [II.3(II.3)]; PMID:30250467 [M.II.3]; PMID:29729943 [Fam.M:II.3(M.II.3 (37))]; PMID:27418640 [P21(II.3)]; PMID:35087518 [11.1] |
105102 | M | 215640![]() |
5 | European | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.A:III.3(III.3)]; PMID:29477724 [Fam.A:III.3(III:3)]; PMID:150198 [Fam.AU:III.3(236)]; PMID:32918165 [Fam.A:III.3(Index)] |
105112 | F | 215646 | - | Herpes Simplex Virus Infection | NFKB1 insufficiency | PMID:27379089 [P5]; PMID:32278790 [BM.I.5]; PMID:29403474 [Patient 5 (10)]; PMID:150198 [Fam.AJ:147] | |
105129 | M | 215647![]() |
- | Varicella zoster virus infection | NFKB1 insufficiency | PMID:27379089 [Fam.1:c1(P1)]; PMID:32278790 [Fam.BA:II.1(II.1)]; PMID:29403474 [Fam.(10):c1(Patient 1)]; PMID:150198 [Fam.AG:IV.1(143)] | |
105130 | F | 215647![]() |
- | Varicella zoster virus infection | NFKB1 insufficiency | PMID:27379089 [Fam.1:c2(P2)]; PMID:32278790 [Fam.BA:II.2(II.2)]; PMID:29403474 [Fam.(10):c2(Patient 2)]; PMID:150198 [Fam.AG:IV.2(144)] | |
105142 | M | 210314![]() |
- | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.BF:II.1(II.1)]; PMID:29403474 [Fam.(13):II.2(Patient 3)]; PMID:27923702 [Fam.191:II.2(Patient 3)]; PMID:150198 [Fam.AO:II.3(165)] |
105180 | M | 215662 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.S:II.1(S.II.1 (47))]; PMID:27102614 [Fam.D:II.1(5)] |
105194 | M | 215665![]() |
2 | Iranian | Varicella zoster virus infection | Immunodeficiency, common variable, 8 | PMID:27888588 [Case(II.1)] |
105197 | M | 215666![]() |
25 | Finnish | Herpes Simplex Virus Infection | NFKB1 insufficiency | PMID:32278790 [Fam.F1:III.3(III.3)]; PMID:29403474 [Fam.1 (9):III.3(F1.III-3)]; PMID:28115215 [Fam.1:III.3(F1.III-3)]; PMID:150198 [Fam.AQ:III.3(177)]; PMID:36356849 [Fam.6:III.3(F6:III:3)]; PMID:36105815 [Fam.H67R:III.3(H67R/4)] |
105212 | F | 215666![]() |
- | Finnish | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.F1:II.4(II.4)]; PMID:29403474 [Fam.1 (9):II.4(F1.II-4)]; PMID:28115215 [Fam.1:II.4(F1.II-4)]; PMID:150198 [Fam.AQ:II.4(174)]; PMID:36356849 [Fam.6:II.4(F6:II:4)]; PMID:36105815 [Fam.H67R:II.4(H67R/2)] |
105220 | F | 215666![]() |
- | Finnish | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.F1:III.8(III.8)]; PMID:29403474 [Fam.1 (9):III.8(F1.III-8)]; PMID:28115215 [Fam.1:III.8(F1.III-8)]; PMID:150198 [Fam.AQ:III.8(182)]; PMID:36356849 [Fam.6:III.8(F6:III:8)]; PMID:36105815 [Fam.H67R:III.8(H67R/7)] |
105231 | M | 215671![]() |
- | Finnish | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.F2:III.2(III.2)]; PMID:29403474 [Fam.2 (9):III.2(F2.III-2)]; PMID:28115215 [Fam.2:III.2(F2.III-2)]; PMID:150198 [Fam.AR:III.2(193)]; PMID:36356849 [Fam.5:III.2(F5:III:2)] |
105332 | U | 215694 | - | European | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [M.II.1]; PMID:29477724 [Fam.M:II.1(II:1)]; PMID:150198 [Fam.BG:285] |
105337 | U | 215699 | 12 | European | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [I.II.1]; PMID:29477724 [Fam.I:II.1(I:II-1)]; PMID:150198 [Fam.BC:268] |
105348 | M | 215710 | - | Varicella zoster virus infection | Combined immunodeficiency with skin-hair depigmentation | PMID:29408330 [P1(II.-)] | |
105349 | F | 215711 | 9,9 | Herpes Simplex Virus Infection,Varicella zoster virus infection | Combined immunodeficiency with skin-hair depigmentation | PMID:29408330 [P2] | |
105363 | F | 215722 | - | Afro-American | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.X:II.1(X.II.1 (59))]; PMID:28366794 [Fam.A:II.1(P1)] |
105428 | M | 215766![]() |
0 | Admixed | Herpes Simplex Virus Infection | Adenosine deaminase 2 deficiency | PMID:26867732 [Fam.F:II.2(P9)]; PMID:25457153 [Fam.1:II.3(P2)]; PMID:25075846 [Fam.1:II.3(younger-sib)] |
105450 | F | 215770![]() |
- | Caucasian | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [BI.I.1]; PMID:150198 [Fam.BU:II.1(337)]; PMID:31803180 [Fam.D:II.1(S7)]; PMID:34619682 [P.150] |
105453 | M | 215771![]() |
6 | Caucasian | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [BO.I.2]; PMID:150198 [Fam.BV:II.3(342)]; PMID:31803180 [Fam.E:II.3(S8)]; PMID:36105815 [Fam.R157P:II.3(S8)] |
105546 | M | 215800![]() |
- | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29867916 [N211(II.1)]; PMID:29729943 [Fam.O:II.1(O.II.1 (42))] |
105623 | M | 215822 | 2 | Caucasian | Varicella zoster virus infection | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:II.6(P2)] |
105628 | F | 215822 | - | Caucasian | Herpes Simplex Virus Infection | Activated p110-delta syndrome 1 | PMID:25352054 [Fam.1:III.3(P5)] |
105657 | F | 215835 | - | Herpes Simplex Virus Infection | Activated p110-delta syndrome 1 | PMID:27379089 [11] | |
105660 | F | 215836 | 3 | Varicella zoster virus infection | Activated p110-delta syndrome 1 | PMID:26437962 [Fam.A:II.3(Sibling 3)] | |
105679 | M | 215839![]() |
2 | Caucasian | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [Fam.BH:II.2(II.2)]; PMID:150198 [Fam.CD:II.1(409)] |
105775 | F | 215868 | 36 | German | Varicella zoster virus infection | NFKB1 insufficiency | PMID:32278790 [BX.I.1]; PMID:150198 [Fam.DI:466]; PMID:36105815 [Y286N] |
105847 | M | 215890![]() |
- | Spanish | Varicella zoster virus infection | Immunodeficiency, common variable, 14 | PMID:37876937 [Fam.5:II.1(5.1)] |
105910 | F | 215905 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:30250467 [K.II.1]; PMID:29729943 [Fam.K:II.1(K.II.1 (33))] |
105926 | M | 215909 | - | Japanese | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.N:III.2(N.III.2 (41))]; PMID:35087518 [Fam.12:III.2(12.4)] |
105968 | M | 215916 | -,4 | Japanese | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.U:II.1(U.II.1 (50))]; PMID:30048690 [Fam.1:II.1(P1.2)]; PMID:35087518 [Fam.13:II.1(13.2)] |
105974 | M | 215918 | - | Japanese | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.W:I.1(W.I.1 (54))]; PMID:30048690 [Fam.2:I.1(P2.1)]; PMID:35087518 [Fam.15:I.1(15.1)] |
105977 | F | 215918 | - | Japanese | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.W:II.2(W.II.2 (56))]; PMID:30048690 [Fam.2:II.2(P2.2)]; PMID:35087518 [Fam.15:II.2(15.3)] |
105981 | M | 215919 | - | Caucasian | Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.Y:II.1(Y.II.1 (61))] |
106041 | M | 215926 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.EE:II.1(EE.II.1 (76))] |
106047 | F | 215930 | -,- | Caucasian | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.LL:II.1(LL.II.1 (86))] |
106051 | F | 210991 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.NN:II.2(NN.II.1 (89))] |
106057 | F | 210991 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.NN:II.8(NN.II.6 (90))] |
106068 | M | 215931 | -,- | Caucasian | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.PP:II.1(PP.II.1 (96))] |
106094 | M | 215947 | - | Caucasian | Herpes Simplex Virus Infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [Fam.VV:II.1(VV.II.1 (124))] |
106200 | F | 215975![]() |
66,66 | Finnish | Herpes Simplex Virus Infection,Varicella zoster virus infection | NFKB1 insufficiency | PMID:150198 [Fam.FM:III.2(693)]; PMID:36356849 [Fam.2:III.2(F2:III:2)] |
106216 | F | 215975![]() |
32,20 | Finnish | Herpes Simplex Virus Infection,Varicella zoster virus infection | NFKB1 insufficiency | PMID:150198 [Fam.FM:IV.2(701)]; PMID:36356849 [Fam.2:IV.2(F2:IV:2)] |
106313 | F | 215982 | -,- | Caucasian | Herpes Simplex Virus Infection,Varicella zoster virus infection | CTLA4 haploinsufficiency with autoimmune infiltration | PMID:29729943 [P1] |
106320 | M | 215984 | - | Varicella zoster virus infection | NFKB1 insufficiency | PMID:150198 [Fam.EX:608]; PMID:36105815 [L196V] | |
106347 | M | 215994 | 25 | Varicella zoster virus infection | NFKB1 insufficiency | PMID:150198 [Fam.EY:609]; PMID:36105815 [R198C] | |
106363 | F | 216001![]() |
1 | Argentinian | Varicella zoster virus infection | Immunodeficiency 117 | PMID:36736301 [Fam.A:II.1(P1)] |
106448 | F | 216016![]() |
2 | Japanese | Herpes Simplex Virus Infection | Autoinflammation, panniculitis, and dermatosis syndrome 2 | PMID:38914362 [Fam.R:II.1(130)]; PMID:38652464 [Fam.1:II.1(Patient)] |
106555 | M | 216078![]() |
1 | Caucasian | Varicella zoster virus infection | Adenosine deaminase 2 deficiency | PMID:26867732 [Fam.A:II.1(P1)]; PMID:25075845 [Fam.1:II.2(Young-bro)] |
106811 | M | 216157 | 30 | German | Varicella zoster virus infection | Immunodeficiency, common variable, 14 | PMID:39059757 [P3] |
106957 | F | 216198 | - | Herpes Simplex Virus Infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:30092289 [P13] | |
107096 | F | 216332 | - | Japanese | (unusual) Viral infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:33501615 [P3] |
107100 | M | 216334![]() |
2 | Japanese | Varicella zoster virus infection | Infantile-Onset Multisystem Autoimmune Disease 1 | PMID:33501615 [Fam.5:II.1(P5.1)] |
107151 | M | 216364![]() |
- | Turkish | Herpes Simplex Virus Infection | Hyper-IgE recurrent infection syndrome 2 | PMID:39437980 [Fam.A:II.1(Patient 1)] |
107156 | F | 216365![]() |
1 | Turkish | Herpes Simplex Virus Infection | Hyper-IgE recurrent infection syndrome 2 | PMID:39437980 [Fam.B:II.2(Patient 2)] |
*Age: age reported at the first known time of manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).